amplitude surgical investor relations
Profil société AMPLITUDE SURGICAL | AMPLI | FR0012789667 | Bourse Paris, Activités, Actionnaires, Dirigeants de la valeur AMPLITUDE SURGICAL, retrouvez toute l'info sur Investir - Les Echos Bourse. Investor Relations & Financial Communications. PAI Partners S.à r.l. SIGNING OF THE CONTRACT RELATIVE TO THE ACQUISITION OF A MAJORITY STAKE IN AMPLITUDE SURGICAL BY PAI PARTNERS Valence (France), September 18, 2020, 07:00 pm CEST - Further to the press release of July 30, 2020 announcing that Apax Partners and the Management of Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) (the "Company") had … Amplitude Surgical Philippe Garcia CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Théodora Xu amplitude@newcap.eu +33 (0)1 44 71 20 42 We would like to welcome PAI Partners and are pleased to start this new partnership”. The implementation of the public tender offer is subject to the AMF clearance decision, and its completion could take place during the fourth quarter of 2020. © PAI 2021. PAI and PAI Partners are registered trademarks. +66.4% on the volume-weighted average share price over the last 120 trading days. Amplitude Surgical est coté sur le marché Euronext Paris, compartiment B. Fondée en 1997 à Valence, Amplitude Surgical développe et commercialise des produits haut de gamme destinés à la chirurgie orthopédique couvrant les principales pathologies affectant la hanche, le genou et les extrémités, notamment pour les chirurgies du pied et de la cheville. Marc a 10 postes sur son profil. Amplitude Surgical. Today, our products are used in over 400 healthcare facilities in France, and we have sold over 180,000 implants and prostheses worldwide in the past three years, including more than 70,000 in FY 2018 alone. AMPLITUDE develops and markets high-end products for orthopaedic surgery, covering the main disorders affecting the hip, knee and extremities, particularly foot and ankle surgery. Funds managed and advised by Apax Partners exceed €4 billion. AMPLITUDE develops and markets high-end products for orthopaedic surgery, covering the main disorders affecting the hip, knee and extremities, particularly foot and ankle surgery. The proposed transaction which could be completed in the second half of 2020, remains subject to regulatory approvals in France and abroad. Amplitude surgical : cours, cotations, analyses et graphique de l'action Amplitude surgical. The Company undertakes to publish or disclose any adjustments or updates to this information as part of the periodic and permanent information obligation to which all listed companies are subject. AMPLI en temps réel sur Boursorama : historique de la cotation sur Euronext Paris, graphique, actualités, consensus des analystes et informations boursières Stock analysis for Amplitude Surgical SAS (AMPLI:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 … Daniel Caille, independent Board Member, will be in charge of the review of the tender process and the steps enabling a reasoned opinion to be issued at the appropriate time. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 … It is specified that neither Olivier Jallabert nor the two representatives of Apax Partners on the Company’s Board of Directors took part in discussions or voted at this Board Meeting. The Company’s Board of Directors will have to issue its reasoned opinion on the merits of the public offer and its consequences for the Company, its shareholders and its members of staff. The Group recorded annual sales of €88.3 million and unaudited EBITDA of approximately €17.5 million. Learn about our approach to corporate governance . Offer price range: € 18.26 to € 24.34 per share Read More. I would like to thank Apax Partners for their support over the last decade, including the last few months during which the Group has had to cope with an unprecedented global health crisis. This release contains forward-looking statements that are based on assessments or assumptions that were reasonable at the date of the release, and which may change or be altered due, in particular, to random events or uncertainties and risks relating to the economic, financial , regulatory and competitive environment, the risks set out in the 2018/2019 Universal Registration Document, and any risks that are unknown or non-material to date that may subsequently occur. Amplitude Surgical Philippe Garcia, +33 (0)4 75 41 87 41 CFO finances@amplitude-surgical.com or NewCap Investor Relations Marc Willaume, +33 (0)1 44 71 00 13 amplitude@newcap.eu or NewCap Media Relations Nicolas Merigeau, +33 (0)1 44 71 98 55 amplitude@newcap.eu Amplitude surgical: Au bout de 10 ans de litige avec l'Urssaf, … 23/11/18 Amplitude surgical : Le CA trimestriel en hausse de +10,1% +33 (0)1 44 71 94 94, NewCap SEC Filings. Founded in 1997 in Valence, France, AMPLITUDE is a leading French player on the global surgical technology market for lower-limb orthopaedics. +33 (0)1 44 71 94 98. Amplitude Surgical, which was founded in 1997, is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 … Our goal is to tap into new markets while bringing to market innovative new devices and equipment benefiting practitioners and their patients. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. Founded in 1997 in Valence, France, AMPLITUDE is a leading French player on the global surgical technology market for lower-limb orthopaedics. approximately €115 million; and. Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. finances@amplitude-surgical.com Amplitude Surgical - 2017-18 annual results: sales of over €100 million, up +8% like-for-like, and solid EBITDA growth of +17% ... | February 8, 2021 A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. 443 837 331. Voir le profil de Marc Bernard sur LinkedIn, le plus grand réseau professionnel mondial. Amplitude Surgical NewCap NewCap Dimitri Borchtch Investor Relations Media Relations CFO Mathilde Bohin/Thomas Grojean Nicolas Merigeau finances@amplitude-surgical.com amplitude@newcap.eu More. Media Relations Investor Relations Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. The Company will keep the market informed of the appointment process of the independent expert as well as the details of his mission. AMPLITUDE … See the latest releases from Amplitude Healthcare Acquisition Corporation. 19,799,596 shares representing approximately 41.4% of the share capital, Olivier Jallabert, the Company’s founder, Chairman and CEO, and certain other senior executives (“. NewCap. AMPLITUDE develops and markets high-end products for orthopaedic surgery, covering the main disorders … See the latest filings from Amplitude Healthcare Acquisition Corporation. Amplitude Surgical Philippe Garcia Chief Financial Officer philippe.garcia@amplitude-ortho.com +33 (0)4 75 41 87 41 or NewCap Investor Relations Marc Willaume amplitude@newcap.fr +33 … Amplitude Surgical NewCap NewCap Dimitri Borchtch Investor Relations Media Relations CFO Mathilde Bohin/Thomas Grojean Nicolas Merigeau finances@amplitude-surgical.com amplitude@newcap.eu Consultez le profil complet sur LinkedIn et découvrez les relations de Marc, ainsi que des emplois dans des entreprises similaires. PAI Partners is characterised by its industrial approach to ownership combined with its sector-based organisation. B136689. In addition, the group offers orthopedic instruments, technical support and logistics services. It is a great opportunity for us to invest in such a prestigious group and with such a talented management team.”, Bertrand Pivin, Partner at Apax Partners, said: Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 … In close collaboration with surgeons, AMPLITUDE develops, numerous high value … An independent expert will be appointed shortly and will prepare a report on the financial terms of the tender offer in accordance with the provisions of article 261-1 of the AMF stock market authority’s General Regulations. In close collaboration with surgeons, AMPLITUDE develops, numerous high value … See our trading information on NASDAQ.com. Corporate Governance. Apax Partners is a leading European private equity firm. Founded in 1997 in Valence, France, AMPLITUDE is a leading French player on the global surgical technology market for lower-limb orthopaedics. Amplitude Surgical Philippe Garcia CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Théodora Xu amplitude@newcap.eu +33 (0)1 44 71 20 42 NewCap Media Relations Nicolas Merigeau amplitude@newcap.eu +33 (0)1 44 71 98 55 The price of €2.15 per share represents a premium of: The Company’s Board of Directors, which met today, has favorably welcomed the potential acquisition of a majority stake by PAI Partners, and has decided to cooperate in order to allow the tender offer to be filed by the SPV controlled by PAI Partners as swiftly as possible. +33 (0)4 75 41 87 41. This press release must not be published, broadcast or distributed, directly or indirectly, in any countries in which the distribution of this information is subject to legal restrictions. Valence (France), July 30, 2020, 11:30 pm CEST – PAI Partners has entered into exclusive negotiations with a view to acquiring a majority stake in Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) (the “Company”), a French leader on the global surgical technology market for lower-limb orthopedics. amplitude@newcap.eu Apax Partners acquired Amplitude Surgical in 2011, carried out its IPO in 2015 and has been supporting its growth, with annual sales having increased from €45m in 2010-2011 to nearly €90m at 30 June 2020. an EBITDA margin of between 23 and 24% in 2020-21 (ending June 30, 2021), thus delaying by a year the target EBITDA margin presented in the universal registration document filed on November 19, 2019. Amplitude Surgical announces that Apax Partners and the company’s management have entered into exclusive negotiations with PAI Partners in relation to the acquisition of a majority stake in Amplitude Surgical, followed by a mandatory public tender offer. These funds invest in fast-growing small and mid-sized companies across four sectors of specialisation: Tech & Telecom, Consumer, Healthcare and Services. Investor Relations Mathilde Bohin/Thomas Grojean amplitude@newcap.eu +33 (0)1 44 71 94 94 NewCap Media Relations Nicolas Merigeau amplitude@newcap.eu +33 (0)1 44 71 94 98 AMPLI Euronext Paris, sa capitalisation boursière et ses principales activités sur Boursorama Amplitude Surgical finances@amplitude-surgical.com. a recovery of the activity due to the sanitary crisis and a return to the average annual growth trajectory of 5%, as presented in the universal registration document filed on November 19, 2019, resulting in 2020-21 (ending June 30, 2021) sales of around 10% above sales recorded in 2018-19 (ending June 30, 2019), i.e. The funds managed by Apax Partners would dispose their entire stake in the company in cash for €2.15 per share, i.e. Its sales have doubled and its EBITDA has almost tripled, thanks in particular to strong international expansion, the creation of Novastep – its Foot and Ankle subsidiary – and continuous innovation, particularly in the fields of assisted navigation and 3D printing. The Company’s 2019-20 fiscal year was significantly impacted by the COVID-19 pandemic. PAI Partners would acquire, for a price of €2.15 per share and via a special purpose vehicle (the SPV), all the shares directly or indirectly held by Apax Partners and certain managers of the Company, through disposals in cash at a price of €2.15 per share and through contributions of shares based on the same valuation of the Company: The SPV would thus acquire approximately 52.3% of the Company’s share capital1 and voting rights. Press Releases. Suivez en direct la cotation de l'action AMPLITUDE SURGICAL à la Bourse de Paris, découvrez les analyses, les recommandations et toute l'actualité de AMPLITUDE SURGICAL sur Investir - … At June 30, 2020, Amplitude Surgical had a workforce of 436 employees and recorded sales of nearly 90 million euros. Amplitude Surgical specializes in the design, manufacture and marketing of implants dedicated to surgery of knee and hip for hospitals. Créé en 1997, Amplitude Surgical est un acteur français de premier plan sur le marché mondial des technologies chirurgicales destinées à lorthopédie des membres inférieurs. Amplitude Surgical : mise à disposition du document de référence 2016-17 comprenant le rapport financier annuel et l’actualisation des objectifs financiers de la société PDF 18 octobre 2017 PAI Partners S.à r.l. amplitude@newcap.eu. The transfer of our controlling interest to a recognized player in healthcare investment will provide liquidity for all shareholders and enable the company to pursue its rapid expansion.”. It provides the companies it owns with the financial and strategic support required to pursue their development and enhance strategic value creation. Read More. Amplitude Surgical Dimitri Borchtch CFO finances@amplitude-surgical.com +33 (0)4 75 41 87 41 NewCap Investor Relations Théodora Xu amplitude@newcap.eu +33 (0)1 44 71 20 42 Dimitri Borchtch, CFO Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States.
Cepilla Cepilla Fulanito, Contentsquare Lever, Stacy Youtube Infantil, Membrane Acoustique Pour Céramique, Lolaclrvms Tiktok,
